Evidence map›Paper›PMID 37507606›Full record

ArticleNature medicine2023

A synthetic control arm for refractory metastatic colorectal cancer: the no placebo initiative.

Takayuki Yoshino, Qian Shi, Toshihiro Misumi, Hideaki Bando, Masashi Wakabayashi, Morteza Raeisi, Thierry Andre, Aimery de Gramont

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takayuki YoshinoDepartment of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. tyoshino@east.ncc.go.jp.ORCID 0000-0002-0489-4756
Qian ShiDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-4640-8832
Toshihiro MisumiDepartment of Data Science, National Cancer Center Hospital East, Chiba, Japan.
Hideaki BandoDepartment of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Masashi WakabayashiDepartment of Data Science, National Cancer Center Hospital East, Chiba, Japan.
Morteza RaeisiFondation A.R.CA.D, Aide et Recherche en CAncérologie Digestive, Levallois-Perret, France.ORCID 0000-0002-9999-4097
Thierry AndreFondation A.R.CA.D, Aide et Recherche en CAncérologie Digestive, Levallois-Perret, France.ORCID 0000-0002-5103-7095
Aimery de GramontFondation A.R.CA.D, Aide et Recherche en CAncérologie Digestive, Levallois-Perret, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colonic NeoplasmsColorectal NeoplasmsRectal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsDouble-Blind MethodHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.